Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (2623)	5/20/1998 4:17:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Excerpt from a Dow Jones article on U.S. Surgical: Meanwhile Boston Scientific, another oft-cited potential acquirer [of U.S. Surgical], is preoccupied with its own challenges. Sources say the company is a finalist in the bidding for Pfizer Inc.'s (PFE) Schneider Worldwide medical-device unit. But the company's bid appears to be short of Pfizer's target price of $2 billion to $2.2 billion, the sources said. In addition, speculation continues about whether Boston Scientific will buy out its Israel-based coronary-stent partner, Medinol Ltd.